|
ASCO - Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy (décembre 2021)
|
|
ESMO - Management of toxicities from immunotherapy (octobre 2022)
|
|
MASCC - 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors (septembre 2020)
|
|
NCCN - Management of Immunotherapy-Related Toxicities ***connexion requise*** (décembre 2024)
|
